RELMADA THERAPEUTICS, INC. Effective Tax Rate
RELMADA THERAPEUTICS, INC. (RLMD) reported Effective Tax Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-03-19
- RELMADA THERAPEUTICS, INC. effective income tax rate reconciliation, percent for fiscal 2025 was 0.00%.
- RELMADA THERAPEUTICS, INC. effective income tax rate reconciliation, percent for fiscal 2024 was 0.00%.
- RELMADA THERAPEUTICS, INC. effective income tax rate reconciliation, percent for fiscal 2023 was 0.00%.
- RELMADA THERAPEUTICS, INC. effective income tax rate reconciliation, percent for fiscal 2022 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-03-19 | |
| 2024-12-31 | 0.00% 10-K · filed 2026-03-19 | |
| 2023-12-31 | 0.00% 10-K · filed 2025-03-27 | |
| 2022-12-31 | 0.00% 10-K · filed 2024-03-19 | |
| 2021-12-31 | 0.00% 10-K · filed 2023-03-23 | |
| 2020-12-31 | 0.00% 10-K · filed 2022-03-25 | |
| 2019-12-31 | 0.00% 10-K · filed 2021-03-24 | 0.00% 10-K · filed 2021-03-24 |
| 2019-06-30 | 0.00% 10-K · filed 2021-03-24 | |
| 2018-12-31 | 0.00% 10-KT · filed 2020-03-26 | |
| 2018-06-30 | 0.00% 10-KT · filed 2020-03-26 | |
| 2017-06-30 | 0.00% 10-K · filed 2018-09-28 | |
| 2016-06-30 | 0.00% 10-K · filed 2017-09-28 | |
| 2015-06-30 | 0.00% 10-K · filed 2016-09-09 | |
| 2014-12-31 | 0.00% 10-K · filed 2015-09-11 | |
| 2014-06-30 | 0.00% 10-KT · filed 2014-09-09 | |
| 2013-12-31 | 0.00% 10-K · filed 2015-09-11 | |
| 2013-08-31 | 34.00% 10-K · filed 2013-12-16 | |
| 2012-12-31 | 0.00% 10-KT · filed 2014-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |